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An awake craniotomy is a procedure used for the resection of brain tumours from the eloquent cortex and during surgeries for 
epilepsy and movement disorders.1 This technique 
is also used for the management of aneurysms and 
arteriovenous malformations near key areas of the 
brain, such as areas responsible for movement, lang-
uage, sensation, vision, hearing, thought processing, 
fine motor skills and coordination. The principal 
advantage of this technique is that it permits lesion 
removal without compromising the functional inte-
grity of the brain by damaging the eloquent cortex, 
therefore resulting in enhanced neurological recovery.1 
Growing evidence also indicates that there are greater 
survival benefits associated with an awake craniotomy.2 
Other advantages include shorter intensive care unit 
(ICU) and overall hospital stays, a decreased incidence 
of postoperative complications such as nausea and 
vomiting and significantly reduced cost of care.3
Case Report
A 29-year-old man presented to the Khoula Hospital, 
Muscat, Oman, in 2016 with a two month history 
of headaches and convulsions. He had initially been 
managed at a peripheral hospital where a computed 
Departments of 1Anaesthesia & Intensive Care and 2Neurosurgery, Khoula Hospital, Muscat, Oman
*Corresponding Author e-mail: nilay.chatt@gmail.com 
ة من  مزيج من الدكسميديتوميدين )باجلرعة املستمرة( مع جرعة خمفضة ومعريَّ
الفنتانيل و الربوبوفول يف عملية حج القحف واملريض يف وعيه
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abstract: An awake craniotomy is a continuously evolving technique used for the resection of brain tumours 
from the eloquent cortex. We report a 29-year-old male patient who presented to the Khoula Hospital, Muscat, 
Oman, in 2016 with a two month history of headaches and convulsions due to a space-occupying brain lesion in 
close proximity with the left motor cortex. An awake craniotomy was conducted using a scalp block, continuous 
dexmedetomidine infusion and a titrated ultra-low-dose of propofol-fentanyl. The patient remained comfortable 
throughout the procedure and the intraoperative neuropsychological tests, brain mapping and tumour resection were 
successful. This case report suggests that dexmedetomidine in combination with titrated ultra-low-dose propofol-
fentanyl are effective options during an awake craniotomy, ensuring optimum sedation, minimal disinhibition and 
a rapid recovery. To the best of the authors’ knowledge, this is the first awake craniotomy conducted successfully 
in Oman.
Keywords: Anesthesia; Craniotomy; Dexmedetomidine; Propofol; Fentanyl; Case Report; Oman.
امللخ�ص: حج القحف )�صق اجلمجمة( اأثناء الوعي هي تقنية تتطور با�صتمرار ال�صتئ�صال اأورام املخ من الق�رضة البليغة، ح�رض مري�ض يبلغ 
من العمر 29 عامًا اإىل م�صت�صفى خولة، م�صقط، �صلطنة عمان، يف عام 2016. وكان يعاين املري�ض من ال�صداع امل�صتمر والت�صنجات ملدة 
�صهرين ب�صبب ورم بالدماغ على مقربة من الق�رضة احلركية الي�رضى، ثم اأجريت عملية حج القحف واملري�ض يف حالة الوعي با�صتخدام 
ة من الفنتانيل و الربوبوفول،  تخدير فروة الراأ�ض املو�صعي مع مزيج من الدك�صميديتوميدين )باجلرعة امل�صتمرة( و جرعة خمف�صة ومعريَّ
ظل املري�ض يف حالة ارتياح وا�صتقرار من خالل ا�صتئ�صال الورم كما اأظهر ذلك ر�صم خرائط الدماغ وجميع االإختبارات النف�صية الع�صبية 
اأثناءالعملية. ي�صري هذا التقرير اإىل فعالية ا�صتخدام املزيج املذكور يف التخدير لعملية حج القحف واملري�ض يف وعيه مما قد ي�صاعد يف 
حدوث تخدير اأف�صل و اإزالة تثبيط اأقل و اإعادة ا�صتقرار �رضيع، بالن�صبة للموؤلفني تعترب عملية حج القحف واملري�ض يف وعيه االأوىل من 
نوعها يف �صلطنة عمان.
كلمات مفتاحية: التخدير؛ حج القحف؛ الديك�صميديتوميدين؛ الربوبوفول؛ الفنتانيل؛ تقرير حالة؛ ُعمان.
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tomography scan of the brain revealed a left fronto-
parietal parafalcine lesion measuring 3.7 x 3.6 x 3.0 cm. 
He was prescribed antiepileptics including dexa-
methasone and referred to the Khoula Hospital, a 
tertiary care neurosurgical centre. Before referral, 
the patient had multiple episodes of left-sided jerky 
movements in his upper limbs. 
Magnetic resonance imaging revealed a left 
cortical-subcortical frontal gyrus lesion surrounded 
by oedema with peripheral diffusion restriction. The 
lesion reached the premotor cortex and was in close 
proximity with the motor cortex, although it did not 
affect the left precentral gyrus [Figure 1]. Considering 
the critical location of the lesion, an awake craniotomy 
was scheduled. The patient was counselled by both a 
neurosurgeon and neuroanaesthesiologists and given 
a detailed explanation of the procedure, including 
the benefits and associated risks and the need for 
intraoperative neuropsychological testing. He was 
reassured that any complications arising during the 
procedure would be addressed immediately. During 
the pre-anaesthetic check-up, the patient’s airway was 
assessed and the results of previous investigations 
were reviewed. Anticonvulsants and dexamethasone 
were continued as previously prescribed and 7.5 mg 
of midazolam was administered orally the night before 
the procedure. 
On the day of the surgery, 4 mg of ondansetron, 
40 mg of pantoprazole and 7.5 mg of midazolam were 
administered to the patient at 6 am. After the patient 
was transferred to the operating theatre, a 16G 
intravenous cannula and a 20G arterial cannula 
in the left radial artery were placed under local 
anaesthesia. Standard monitoring as recommended 
by the American Society of Anesthesiologists was 
initiated.4 Dexmedetomidine was infused (1 µg/kg 
over the first 10 minutes as a loading dose followed by 
0.5 µg/kg/hour), along with propofol (50 µg/kg/minute) 
and fentanyl (0.01 µg/kg/minute). The patient was 
oxygenated through a face mask (4 L/minute) and 
end-tidal carbon dioxide was monitored by attaching 
the sampling tube to the inner surface of the mask. 
The propofol and dexmedetomidine infusions were 
adjusted to maintain a Ramsay Sedation Scale score 
of between 2–3. A scalp block was applied bilaterally, 
targeting the nerves supplying the scalp (e.g. the 
supratrochlear, supraorbital, zygomaticotemporal, 
auriculotemporal, great auricular and greater and 
lesser occipital nerves). Approximately 2–3 mL of 
0.25% bupivacaine was used for each nerve. The head 
was positioned and fixed using skull pins (MAYFIELD® 
Skull Pins, Integra LifeSciences Corp., Plainsboro, 
New Jersey, USA) applied 15 minutes after the scalp 
block. Surgical drapes were adjusted so as to maintain 
easy access to the patient’s airway. Considering the 
patient’s cooperation and level of tolerance, it was 
decided that he would be kept awake throughout 
the craniotomy. An emergency plan was formulated 
to secure the patient’s airway with a laryngeal mask 
airway device (LMA ProSeal™, Teleflex® Incorporated, 
Wayne, Pennsylvania, USA), if needed. Before starting 
the surgery, the dura was infiltrated with 10 mL of 
2% lignocaine. 
The dura incision was made [Figure 2A] without 
the patient complaining of pain. Upon opening 
the dura, increased intracranial pressure was 
 
Figure 1A–F: Magnetic resonance imaging (MRI) of a patient with headaches and convulsions due to a space-occupying 
brain lesion. A: Coronal T2-weighted MRI showing a hyperintense left frontal intra-axial space-occupying lesion in the 
left superior frontal gyrus surrounded by oedema (arrow). B: Coronal fluid-attenuated inversion recovery MRI showing 
peripheral hyperintensity around the lesion (arrow). C: Axial T2-weighted MRI showing the lesion (arrow). D: Sagittal 
post-contrast MRI showing the non-contrast enhancing lesion in the left frontal lobe approaching the motor cortex 
(arrow). E: Diffusion-weighted MRI showing peripheral diffusion restriction of the lesion (arrow). F: MRI spectroscopy 
showing decreased N-acetylaspartate and enhanced choline peaks, indicating a high-grade tumour.
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Figure 2A & B: Photographs of an awake craniotomy performed on a patient with a space-occupying brain lesion 
showing the (A) opening of the dura and (B) resection of the tumour.
and patient are key.3 During awake craniotomies, 
patients do not always remain awake throughout 
the course of the entire surgery. Varying levels of 
sedation or anaesthesia are needed for certain parts 
of the procedure, such as during the scalp incision, 
craniotomy or opening of the dura.3 Depending on the 
anaesthetist’s preference and the extent of the patient’s 
understanding and cooperation, either an “awake 
throughout” or “asleep/awake and asleep” technique 
is selected. In the former technique, only sedation 
and analgaesia are used, whereas the latter includes 
general anaesthesia and involves securing the airway 
with a laryngeal mask airway device during the initial 
“asleep” phase.3 However, regardless of technique, the 
patient must be completely awake during the brain 
mapping and neuropsychological tests. Thereafter, the 
patient can either be kept awake or re-anesthetised 
depending on the situation. A scalp block is frequently 
used for pain relief in both types of awake craniotomy 
techniques.3 To the best of the authors’ knowledge, 
this case reports the first awake craniotomy cond-
ucted successfully in Oman.
The most commonly used anaesthetic agents 
for an awake craniotomy are propofol, opioids 
and dexmedetomidine. An infusion of propofol 
supplemented with an opioid is the most frequently 
used combination, as it improves the quality of the 
analgaesia and reduces hypnotic requirements.3,6–8 
Gignac et al. found no difference in operative 
conditions, electrocorticography findings and stim-
ulation testing results when comparing various 
opioids.9 In another study, both intermittent fentanyl 
and continuous remifentanil infusions resulted in 
similar rates of patient satisfaction, recall and 
intraoperative complications.10 Overall, these opioids 
seem to be equally efficacious for awake craniotomies.6 
Increasingly, the α2 agonist dexmedetomidine is used 
in awake craniotomies due to its unique sedative, 
observed; this was managed with mannitol (0.5 g/kg) 
and frusemide (10 mg). The propofol and fentanyl 
infusions were then stopped and the patient was 
woken completely. Supplemental doses of anti-
convulsants and ondansetron were administered. 
Neuropsychological tests were carried out to check 
the patient’s motor functions, orientation, memory, 
attention, articulation, ability to name pictures and 
objects, read and repeat words and perform arithmetic 
calculations. Additionally, brain mapping by direct 
electrical stimulation using bipolar electrodes was 
performed. The patient remained completely awake, 
cooperative and responsive. The tumour was excised 
[Figure 2B] and cortical mapping ensued. Throughout 
the surgery, the patient remained haemodynamically 
stable and was able to follow verbal commands 
and communicate effectively. The dexmedetomidine 
infusion (0.5 μg/kg/hour) was continued throughout 
the procedure.
After completing the tumour resection, propofol 
and fentanyl infusions were initiated once again and 
the sedation was increased. Following the closure 
of the skin incision, all infusions of sedatives were 
discontinued and the patient was transferred to the 
ICU for observation. Postoperatively, the patient 
exhibited no neurological deficits and his ICU stay was 
uneventful. The patient was transferred to a normal 
ward the following morning and was discharged on the 
fourth postoperative day. Histopathological analysis 
of the lesion revealed it to be an astrocytoma (World 
Health Organization grade II).5 
Discussion
The anaesthetic considerations required for an awake 
craniotomy are challenging. Careful patient selection, 
preoperative preparation and effective commun-
ication between the neuroanaesthetist, neurosurgeon 
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analgaesic and anxiolytic properties and because of 
its minimal effects on ventilation.7 Dexmedetomidine 
reduces opioid requirements by 30–50%, is not 
associated with disinhibition—a common problem 
with propofol and benzodiazepines—and has minimal 
effects on electrocorticography.7 However, no research 
is as yet available to make a direct comparison 
between propofol-opioids and dexmedetomidine for 
awake craniotomies. In the current case, a constant 
infusion of dexmedetomidine and an ultra-low-dose 
infusion of propofol-fentanyl were used to ensure 
optimum sedation, minimal disinhibition and a 
rapid recovery. The propofol-fentanyl infusions were 
halted after the dura was opened to allow the patient 
sufficient time to emerge from sedation and undergo 
intraoperative testing; the necessary amount of time 
has been reported to be approximately nine minutes 
with such combinations.11 The principal advantages 
of this combination are that the propofol-fentanyl can 
be titrated for the individual’s specific physiological 
requirements to maintain sleep and that it can be 
terminated before brain mapping; in addition, it can 
be reinitiated to deepen sedation or to induce a second 
sleep phase if needed.11 
Neuropsychological tests and cortical mapping 
are critical steps during an awake craniotomy.3 During 
this stage, the patient is awoken if asleep beforehand 
and is allowed to gradually adjust to the environment 
before clinical evaluation. Emergence from sedation 
can cause several complications, such as pain and 
discomfort, agitation, nausea and vomiting.3 If any of 
these occur, they should be addressed immediately 
before they lead to poor surgical conditions. The 
objective of cortical stimulation or brain mapping is 
to localise the eloquent areas of the brain—the areas 
involved in speech and language comprehension—
and the motor and sensory cortex through direct 
electrical stimulation of the cerebral cortex.8 If there 
are any alterations in the patient’s speech, language 
or motor function during electrical stimulation, the 
neurosurgeon is immediately notified.12 Once the 
cortex has been mapped functionally, resection of the 
lesion continues.
During cortical mapping, focal or generalised 
seizures have been reported to occur in up to 16% 
of patients undergoing craniotomies with conscious 
sedation.13 These are usually managed by irrigating 
the brain tissue with ice-cold saline; seizures which 
do not respond to ice-cold saline are treated with 
benzodiazepines, anti-epileptics or sedation with 
control of the airway.6 The anaesthetist should always 
have an emergency plan for airway control, keeping 
in mind that securing the airway in a patient whose 
head is fixed in place with skull pins can be extremely 
challenging. The ProSeal™ laryngeal mask airway 
device (Teleflex® Incorporated) is an optimal choice 
in this context.8 Intolerance to the awake craniotomy 
procedure on the part of the patient is the most 
frequently encountered complication, commonly due 
to prolonged or improper positioning, the presence of 
a urinary catheter or the occurrence of intraoperative 
seizures.8 Other known intraoperative adverse events 
include hypoventilation, hypoxia, hypercapnia, hypo- 
or hypertension, brady- or tachycardia, brain swelling, 
anxiety, agitation or fatigue.14,15
Conclusion
An awake craniotomy is a well-tolerated procedure 
with few inherent complications. This case report 
describes a successful awake craniotomy using 
continuous dexmedetomidine combined with ultra-
low-dose titrated propofol-fentanyl infusions. This 
effective combination allows for the rapid titration 
of the sedative to desired levels during the initial 
part of the surgery and the discontinuance of the 
propofol-fentanyl infusion thereafter in order to 
allow the patient to wake up rapidly for intraoperative 
neuropsychological tests and cortical mapping.
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